NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat

Antioxidants and Redox Signaling

Volumn 11, Issue 2, 2009, Pages 193-204

  Turchan Cholewo, Jadwiga ^a   Dimayuga, Vanessa M ^a   Gupta, Sunita ^b   Gorospe, R M Charlotte ^a   Keller, Jeffrey N ^b   Bruce Keller, Annadora J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GLYCOPROTEIN GP 91; GLYCOPROTEIN GP91DS; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; MACROPHAGE; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; WILD TYPE;

ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, MUTANT STRAINS; MICROGLIA; NADPH OXIDASE; NEUROTOXINS; SUPEROXIDES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS; MUS;

EID: 58149095918     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2097     Document Type: Article

References (49)

1. Barger SW and Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 76: 846-854, 2001.
2. Barger SW, Goodwin ME, Porter MM, and Beggs ML. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 101: 1205-1213, 2007.
3. Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, and Nath A. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17beta-estradiol. J Neurochem 78: 1315-1324, 2001.
4. Bruce-Keller AJ, Geddes JW, Knapp PE, McFall RW, Keller JN, Holtsberg FW, Steiner SM, Partharasy S, and Mattson MP. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J Neuroimmunol 93: 53-71, 1999.
5. Chen P, Mayne M, Power C, and Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. J Biol Chem 272: 22385-22388, 1997.
6. Colton AC and Gilbert DL. Production of superoxide by a CNS macrophage, the microglia. FEBS Lett 223: 284-288, 1987.
7. D'Aversa TG, Eugenin EA, and Berman JW. NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81: 436-446, 2005.
8. D'Aversa TG, Yu KO, and Berman JW. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J Neurovirol 10: 86-97, 2004.
9. Day BJ and Kariya C. A novel class of cytochrome P450 reductase redox cyclers: Cationic manganoporphyrins. Tox Sci 85: 713-719, 2005.
10. DeLeo FR and Quinn MT. Assembly of the phagocyte NADPH oxidase: Molecular interaction of oxidase proteins. J Leukoc Biol 60: 677-691, 1996.
11. Ding Q, Dimayuga E, Markesbery WR, and Keller JN. Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J 20: 1055-1063, 2006.
12. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 7: 1223-1233, 2005.
13. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
14. El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ, and Hauser KF. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53: 132-146, 2006.
15. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan R, Wingfield P, and Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type-1 Tat protein on cell growth and viral replication. J Virol 67: 277-287, 1993.
16. Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, and Koenigsberger MR. Neurological manifestations of HIV infection in children with AIDS. Pediatrics 78: 678-687, 1986.
17. Gao HM, Liu B, Zhang W, and Hong JS. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J 13: 1954-1956, 2003.
18. Glass J, Fedor H, Wesselingh SL, and McArthur JC. Immunocytochemical quantification of human immunodeficiency virus in the brain; Correlation with dementia. Ann Neurol 38: 755-762, 1995.
19. Grant I, Sacktor H, and McArthur J. HIV neurocognitive disorders, in The Neurology of AIDS, H.E. Gendelman, et al., eds. 2005, Oxford University Press: London. p. 357-373.
20. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, and Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 20: 146-155, 2001.
21. Heaton RK, Velim RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, and Grant I. Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosomatic Med 56: 8-17, 1994.
22. Hudson L, J L, Nath A, Jones M, Raghavan R, Narayan O, Male D, and Everall I. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 6: 145-155, 2000.
23. Jana A and Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 279: 51451-51459, 2004.
24. Kaul N and Forman HJ. Activation of NF kappa B by the respiratory burst of macrophages. Free Radic Biol Med 21: 401-405, 1996.
25. King JE, Eugenin EA, Buckner CM, and Berman JW. HIV tat and neurotoxicity. Microbes Infect 8: 1347-1357, 2006.
26. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell J, and Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 111: 194-213, 2005.
27. Mankowski JL, Queen SE, Clements JE, and Zink MC. Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol 157: 66-70, 2004.
28. McArthur JC, Brew BJ, and Nath A. Neurological complications of HIV infection. Lancet Neurol 4: 543-555, 2005.
29. McGeer PL and McGeer EG. The role of the immune system in neurodegenerative disorders. Mov Disord 12: 855-858, 1997.
30. Minghetti L, Visentin S, Patrizio M, Franchini L, Ajmone-Cat MA, and Levi G. Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions. Neurochem Res 29: 965-978, 2004.
31. Nakajima K, Tohyama Y, Kohsaka S, and Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci Lett 307: 171-174, 2001.
32. Nelson P, Soma L, and Lavi E. Microglia in diseases of the central nervous system. Ann Med 34: 491-500, 2002.
33. Park L, Anrather J, Girouard H, Zhou P, and Iadecola C. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J Cereb Blood Flow Metab 27: 1908-1918, 2007.
34. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77: 540-551, 2004.
35. Piani D, Spranger M, Frei K, Schaffner A, and Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 22: 2429-2436, 1992.
36. Pu H, Tian J, Andras IE, Hayashi K, Flora G, Hennig B, and Toborek M. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J Cereb Blood Flow Metab 25: 1325-1335, 2005.
37. Qin L, Liu Y, Wang T, Wei S, Block ML, Wilson B, Liu B, and Hong JS. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279: 1415-1421, 2004.
38. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, and Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89: 408-414, 2001.
39. Sheng WS, Hu S, Hegg CC, Thayer SA, and Peterson PK. Activation of human microglial cells by HIV-1 gp41 and Tat proteins. Clin Immunol 96: 243-251, 2000.
40. Stolk J, Hiltermann TJ, Dijkman JH, and Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 11: 95-102, 1994.
41. Streit WJ, Walter SA, and Pennell NA. Reactive microgliosis. Prog Neurobiol 57: 563-581, 1999.
42. Tardieu M, Hery C, Peudenier S, Boespflug O, and Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-tocell adhesion. Ann Neurol 132: 11-17, 1992.
43. Tyor WR, Wesselingh W, Griffith SW, McArther JC, and Griffen DE. Unifying hypothesis of the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J AIDS Human Ret 9: 379-388, 1995.
44. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59: 1428-1459, 2002.
45. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur J, Farber JM, Griffin JW, and Griffin DE. Intracerebral cytokine messenger RNA expression in acquired immunodefiency syndrome dementia. Ann Neurol 33: 576-582, 1993.
46. Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, and Lehmann V. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J 14: 546-554, 1995.
47. Wiley CA, Baldwin M, and Achim CL. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847, 1996.
48. Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, and Cave AC. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113: 1235-1243, 2006.
49. Zhou LZ, Johnson AP, and Rando TA. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med 31: 1405-1416, 2001.